SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER
Active substance: TITANIUM DIOXIDE, OCTINOXATE, ENSULIZOLE
EMULSION · TITANIUM DIOXIDE 1.77 g/40mL, OCTINOXATE 1.71 g/40mL, ENSULIZOLE .428 g/40mL
United StatesActive
Marketing holder: SHISEIDO AMERICAS CORPORATION
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TITANIUM DIOXIDE · 1.77 g/40mL
- OCTINOXATE · 1.71 g/40mL
- ENSULIZOLE · .428 g/40mL
Products containing titanium dioxide in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| EU 1 |
|
Registration
- Registration number
- 58411-657
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- TOPICAL
Sources
- product · openFDA NDC · 58411-657 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58411-657 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58411-657 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 58411-657 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 58411-657 · Verified 2026-10-09 · open in source